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ABSTRACT 
 
 Hydrogels immobilized with biomimetic peptides have been used widely for tissue 
engineering and drug delivery applications. Photopolymerization has been among the most 
commonly used techniques to fabricate peptide-immobilized hydrogels as it offers rapid and 
robust peptide immobilization within a crosslinked hydrogel network. Both chain-growth and step-
growth photopolymerizations can be used to immobilized peptides within covalently crosslinked 
hydrogels. Previously developed visible light mediated step-growth thiol-norbornene gelation 
scheme has demonstrated efficient crosslinking of hydrogels composed of inert poly(ethylene 
glycol)-norbornene (PEGNB) macromer and small molecular weight bis-thiol linker, such as 
dithiothreitol (DTT). Compared with conventional visible light mediated chain-polymerizations 
where multiple initiator components are required, step-growth photopolymerized thiol-norbornene 
hydrogels are more cytocompatible for in situ encapsulation of radical sensitive cells (e.g., 
pancreatic β-cells). This contribution explored visible light based crosslinking of various bis-
cysteine containing peptides with macromer 8-arm PEGNB to form biomimetic hydrogels suitable 
for in situ cell encapsulation. It was found that the addition of soluble tyrosine during 
polymerization not only significantly accelerated gelation, but also improved the crosslinking 
efficiency of PEG-peptide hydrogels as evidenced by a decreased gel point and enhanced gel 
modulus. In addition, soluble tyrosine drastically enhanced the cytocompatibility of the resulting 
PEG-peptide hydrogels, as demonstrated by in situ encapsulation and culture of pancreatic MIN6 
β-cells. This visible light based thiol-norbornene crosslinking mechanism provides an attractive 
gelation method for preparing cytocompatible PEG-peptide hydrogels for tissue engineering 
applications.   
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INTRODUCTION 
 Bioactive or biomimetic hydrogels suitable for drug delivery and tissue engineering 
applications can be fabricated from naturally derived materials such as alginate [1], 
glycosaminoglycans [2-5], fibrin [6, 7], chitosan [8-10], dextran [11], collagen [12], and gelatin [13, 
14]. Although hydrogels derived from natural matrices are inherently bioactive, it remains 
challenging in tuning their bioactivity, mechanics, and degradation features [15]. On the other 
hand, hydrogels prepared from purely synthetic polymers, such as poly(ethylene glycol) (PEG) 
and poly(vinyl alcohol) (PVA), have excellent tunability in material mechanical properties but they 
do not possess bioactive features necessary for promoting cell viability and function [16-18]. 
Hence, biomimetic peptides are routinely used to render the otherwise inert synthetic hydrogel 
bioactive. A classical way of immobilizing peptides in synthetic hydrogel is through chain-growth 
copolymerization of (meth)acrylated macromers and (meth)acrylated peptides [19]. Alternatively, 
cysteine containing peptides could be readily crosslinked with acrylated macromers through a 
mixed-mode thiol-acrylate polymerization [20]. For example, Lin and Anseth incorporated 
cysteine-bearing glucagon-like peptide 1 (GLP-1C) into PEG-diacrylate (PEGDA) hydrogel to 
improve the viability and insulin secretion of encapsulated islets [21]. PEG-peptide hydrogel could 
also be polymerized via Michael-type addition between nucleophilic macromers (e.g., acrylate, 
maleimide, or vinyl sulfone) and cysteine-containing peptides [22-25]. For example, Garcia and 
colleagues synthesized bioactive PEG-peptide hydrogels using 4-arm PEG-maleimide with 
cysteine-containing protease-sensitive and integrin-binding peptides (i.e., CRGDS) to promote 
the performance of encapsulated islets in vivo [26].  
While PEG-peptide hydrogels have found various successful applications, limitations and 
challenges exist. In particular, chain-polymerized hydrogels are known to form network containing 
heterogeneous and hydrophobic polyacrylate kinetic chains and high molecular weight 
degradation products [27-30]. On the other hand, the gelation kinetics of Michael-type hydrogels 
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cannot be easily controlled and the resulting gel network often contains high degrees of structural 
defects [31]. To overcome these issues, Anseth and colleagues developed PEG-peptide 
hydrogels using thiol-norbornene photo-click reaction [32]. In this system, low intensity and long 
wavelength ultraviolet (UV) light (5–10 mW/cm2, 365 nm) was used to generate primary radicals 
from cleavage-type photoinitiators (e.g., lithium acylphosphinate or LAP) [32]. These radicals 
deprotonate thiol groups on cysteine residues of the peptide crosslinkers to afford thiyl radicals 
capable of reacting to norbornene moiety in a strictly step-growth polymerization mechanism. The 
advantages of step-growth thiol-norbornene reaction include rapid, ambient, and aqueous 
reaction conditions, as well as spatial-temporal control over gelation kinetics [33-35]. Furthermore, 
thiol-norbornene photo-click reaction is not susceptible to oxygen inhibition, providing rapid 
gelation when comparing with acrylate-based chain-growth photopolymerizations at equivalent 
macromer concentration and functionality [36, 37]. Thiol-norbornene photo-click reactions also 
limit disulfide bond formation due to radical-mediated disulfide cleavage [38], thus increasing the 
degree of network crosslinking and mechanical properties of the resulting hydrogels [32].  
While current thiol-norbornene hydrogels have shown to be cytocompatible for 
mammalian cells [32, 37, 39-46], the use of UV-light still raised concerns of DNA and protein 
damage [47]. In this regard, we have developed step-growth thiol-norbornene photo-click PEG-
based hydrogels using a visible light source (400 nm to 700 nm) and a type II photoinitiator (e.g., 
eosin-Y) [48]. Mechanistically, eosin-Y could be excited by a visible light source to abstract 
hydrogen from thiol-containing crosslinkers, such as dithiothreitol (DTT), to form thiyl radicals. 
These thiyl radicals then react with the norbornene moieties on multi-arm PEG macromers to form 
thioether bonds and generate carbonyl radicals. Termination occurs when the carbonyl radicals 
abstract hydrogen from other thiol-containing molecules. This reaction scheme not only preserves 
all advantages offered by thiol-norbornene photopolymerization, but also eliminates the use of 
potentially cytotoxic components (i.e., co-initiator and co-monomer) required in the conventional 
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visible light based photopolymerization. We have shown that purely synthetic hydrogels (i.e., 
PEGNB crosslinked with dithiothreitol, DTT) prepared through this reaction were highly 
cytocompatible for in situ encapsulation of pancreatic β-cells and human mesenchymal stem cells 
(hMSCs) [48]. In an attempt to create bioactive hydrogels using visible light thiol-norbornene 
photopolymerization, we replaced DTT with bis-cysteine-bearing peptides as the hydrogel 
crosslinker. However, gelation efficiency was influenced significantly by the sequence of the bis-
cysteine peptides. To improve the crosslinking efficiency of visible light initiated thiol-norbornene 
hydrogels using bis-cysteine peptide linkers, we explored the addition of soluble amino acids 
capable of altering the photo-excitability of eosin-Y [49, 50]. It was discovered that the addition of 
soluble tyrosine could increase the degree of cysteine deprotonation, which led to an 
improvement in thiol-norbornene gelation efficiency. In addition, we systematically studied the 
gelation kinetics and physical properties of PEG-peptide hydrogel formed by visible light initiated 
thiol-norbornene crosslinking in the presence of soluble tyrosine. We further evaluated the 
cytocompatibility of these PEG-peptide hydrogels through in situ encapsulation of both pancreatic 
β-cells and isolated mouse islets.  
 
 
MATERIALS AND METHODS 
Materials  
 8-arm PEG and PEG-amine were purchased from JenKem Technology USA. Linear PEG 
(6 kDa), 5-norbornene-2-carboxylic acid, N,N’-dicyclohexylcarbodiimide (DCC), 4-(dimethylamino) 
pyridine (DMAP) were obtained from Sigma-Aldrich. Fmoc-protected amino acids, N,N,N′,N′-
Tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU) and 
hydroxybenzotriazole (HOBT) were purchased from AnaSpec. All other chemicals were obtained 
from Fisher Scientific unless noted otherwise.  
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PEGNB synthesis 
 Linear PEG-norbornene (PEGdNB, 6 kDa) and PEG-octa-norbornene (PEG8NB, 20 kDa 
and 40 kDa) were synthesized following an established protocol [33]. In brief, 5-norbornene-2-
carboxylic acid (5-fold excess of OH group) and coupling reagent DCC (2.5-fold excess of OH 
group) were added to anhydrous dichloromethane (DCM). The mixture was purged with nitrogen 
and stirred at room temperature for 1 hour. The resulting norbornene anhydride was filtered into 
an addition funnel and added slowly to a flask containing PEG, DMAP (0.5-fold of OH group), and 
pyridine (0.5-fold of OH group) dissolved in anhydrous DCM. The flask was purged with nitrogen, 
kept on ice and allowed to react overnight in dark. The reaction was repeated for the second time 
to improve the functionalization of norbornene on PEG. The product was precipitated in cold ethyl 
ether and collected by filtration. PEGNB product was re-dissolved in double distilled water (ddH2O) 
and proceed with dialysis for 2 days using slightly acidic ddH2O (pH 6.8) to prevent ester 
hydrolysis of PEG8NB. The pure product was obtained from lyophilization (degree of norbornene 
substitution >85 %). PEGNB: 1H NMR (CDCl3, 500 MHz): δ – 4.25 (m, 2H), 5.98 (m, 1H), 6.23 (m, 
1H). 
To synthesize hydrolytically stable 8-arm PEG-amide-norbornene (PEG8aNB), 
norbornene acid (5-fold excess to amine groups) was first activated by HBTU/HOBT (5.5-fold 
excess to amine group) in dimethylformamide (DMF) for 3 minutes. With nitrogen gas purging, 
N,N-Diisopropylethylamine (DIEA, 6-fold excess to amine group) was added to the activated 
norbornene acid solution and stirred for 5 minutes.  The solution was added drop wise to a two-
neck flask containing PEG-octa-amine in DMF. After overnight reaction at room temperature, the 
product was precipitated in cold ethyl ether. PEG8aNB product was dried in vacuuo, re-dissolved 
in water and dialyzed for 2 days. 1H NMR (Bruker 500) was used to confirm the degree of PEG 
functionalization (>90 %). 
Peptide synthesis 
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 All peptides were synthesized in an automated microwave-assisted peptide synthesizer 
(CEM Liberty 1). Crude peptides were cleaved from resins using phenol, trifluoroacetic acid (TFA), 
triisopropylsilane (TIS), and ddH2O. Cleaved peptides were precipitated in cold ethyl ether, 
collected from centrifugation, dried in vacuuo, and purified by reverse phase HPLC (PerkinElmer 
Flexar system). Peptide identity was confirmed by mass spectrometry (Agilent Technologies 
Model 1200-6520).   
Hydrogel fabrication and characterization 
 Step-growth thiol-norbornene hydrogels were formed by visible light mediated photo-click 
reactions using PEG8NB and di-cysteine peptide (i.e., Cys-Gly-Gly-Gly-Cys or CGGGC) in the 
presence of 0.1 mM of eosin-Y. L-tyrosine methyl ester (i.e., soluble tyrosine) dissolved in ddH2O 
was added in selected formulations. The concentration of PEG8NB was adjusted based on 1H 
NMR results to afford correct norbornene concentrations in the gelation mixtures. The precursor 
solution was injected in between two glass slides separated by 1 mm thick spacers or in 1 mL 
syringe mold with an open tip. Hydrogel crosslinking was initiated by exposing the solution to 400-
700 nm light at 70,000 lux (equivalence of 10mW/cm2 at 550 nm) for 5 minutes. To characterize 
gel fractions, hydrogels were immediately dried in vacuuo after gelation. Dry mass (WDry,1) was 
measured and the dried polymers were incubated in ddH2O at 37 oC on an orbital shaker for 24 
hours to remove un-crosslinked (sol fraction) species. The swollen gels were dried again in 
vacuuo and weighed to obtain second dried polymer weights (WDry,2). Gel fractions were obtained 
by the ratio of the two dry masses (i.e., WDry,1/WDry,2). In selected experiments, gels were allowed 
to swell in pH 7.4 PBS for two days prior to obtaining swollen gel weights (WSwollen). Hydrogel 
swelling ratios (q) were defined as the ratio of swollen gel mass to the second dried polymer mass 
(i.e., WSwollen/WDry,2). 
Rheometry 
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  In situ photo-rheometry was performed at room temperature on a Bohlin CVO 100 
digital rheometer equipped with a light cure cell. A macromer solution (100 µL) was placed 
on a quartz plate in the light cure cell and irradiated with the visible light (400-700 nm, 
70,000 lux) through a flexible light guide. Light was turned on 30 seconds after starting 
time-sweep measurement (5 % strain, 1 Hz frequency, and a gap size of 90 µm) using a 
25 mm parallel plate geometry. Gel point (i.e., crossover time) was determined at the time 
when storage modulus (G’) surpassed loss modulus (G”).  
  Oscillatory rheometry in strain-sweep mode was used to obtain elastic modulus of 
the hydrogel. At equilibrium swelling (after 48 hours in pH 7.4 PBS), a biopsy punch was 
used to remove circular gel discs (8 mm in diameter) from the gel slabs. Storage moduli 
of the hydrogels were measured using 8 mm parallel plate geometry with a gap size of 750 
μm. The elastic moduli for each gel formulation (N = 3) were recorded from the average of 
the linear viscoelastic region (LVR, linear portion of G’ plotting against % strain). 
Thiol and norbornene consumption 
Precursor solution containing eosin-Y (at 0.1 mM) and various components (i.e., 
PEGdNB6kDa, L-cysteine HCl, and L-tyrosine methyl ester) was prepared in PBS (pH 7.4) and 
exposed to visible light (400-700 nm, 70,000 lux). Concentrations of the components were 
equivalent to those used in gelation studies (final concentration of norbornene and thiol = 12 mM). 
To determine thiol-consumption, portions of non-gelling solution were collected throughout 5 
minutes of light exposure, and the content of the free thiol was immediately assayed with Ellman’s 
reagent buffer. The thiol concentration presented at the specific time was measured against a 
known standard (i.e., L-cysteine HCl). For norbornene conversion, non-gelling precursor solutions 
were exposed to visible light for 5 minutes, followed by dialysis against ddH2O to remove small 
molecular weight by-products. The samples were freeze-dried, dissolved in chloroform-d, and 
subjected to proton NMR evaluation. 1H NMR was used to evaluate the signature peaks for ethyl 
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protons on PEG backbone (δ 3.9-4.2 ppm, peaks a) and norbornene (δ 5.8-6.2 ppm, peaks b, c). 
The areas of the norbornene peaks were obtained and integrated areas obtained were further 
compared to the area under the norbornene peaks for pure PEGdNB at the same macromer 
concentration. Norbornene consumption was calculated using the difference in the area of the 
norbornene peaks before and after reaction dived by the area before the reaction. 
UV/Vis spectrophotometry  
Eosin-Y (at 0.1 mM) and various components (i.e., PEGdNB6kDa, L-cysteine HCl, and L-
tyrosine methyl ester) were dissolved in PBS (pH 7.4) and exposed to visible light for 5 minutes.  
Non-gelling components were used (e.g., PEGdNB and L-cysteine) to prevent gelation and to 
facilitate solution-based UV/Vis spectrometric measurements.  Concentrations of the components 
were equivalent to those used in gelation studies (final concentration of norbornene and thiol = 
12 mM). Using a microplate reader (BioTek Synergy HT) in UV/Vis absorption mode (wavelength 
between 400 and 700 nm at 2 nm increments), the absorbance spectra of the non-gelling solutions 
were measured before and after the exposure of light. To prevent saturation in absorbance, 
solution was diluted so the final concentration of eosin-Y was 0.02 mM. 
Cell encapsulation and viability 
Mouse insulinoma cells (MIN6, a gift from Prof. Raghu Mirmira of Indiana University 
School of Medicine), were suspended in polymer solutions containing 0.1 mM eosin-Y, PEG8aNB, 
and di-cysteine peptide (i.e., Lys-Cys-Tyr-Ile-Gly-Ser-Arg-Cys-Lys or KCYIGSRCK) with and 
without L-tyrosine methyl ester. Precursor solution was exposed to the same visible light for 5 
minutes to obtain cell-laden hydrogels (cell density in the gels at 5×106 cells/mL, 20 μl/gel), which 
were maintained in high-glucose DMEM supplemented with 10 % fetal bovine serum (FBS), 50 
μM β-mercaptoethanol, and 1× antibiotic-antimycotic. To characterize cell viability, cell-laden 
hydrogels were incubated in 500 μL Almarblue® reagent (10 % in cell culture medium) at 37 oC 
and 5 % of CO2. After 16 hours of incubation, 200 μl of media were transferred to a 96-well plate 
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for fluorescence quantification (excitation: 560 nm and emission: 590 nm). To obtain qualitative 
cell viability, cells were stained with a live/dead staining kit (Calcein AM stained live cells green 
and Edithium homodimer stained dead cells red) and imaged with confocal microscopy (Olympus 
FV-1000 Laser Scanning Biological Microscope). For MIN6 encapsulated gels, three images were 
taken at a step size of 10 µm for a total depth of 100 µm per image.  
Insulin secretion from β-cells 
 To access glucose stimulated insulin secretion (GSIS), cell-laden hydrogels were rinsed 
with HBSS, followed by priming in Krebs-Ringer bicarbonate (KRB) buffer (23 mM sodium chloride, 
1 mM potassium chloride, 4.8 mM sodium bicarbonate, 0.2 mM magnesium chloride hexahydrate, 
0.2 mM calcium chloride dehydrate, 0.5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
and 0.1 vol% bovine serum albumin) containing 2.5 mM glucose for 1 hour at 37 oC and 5 % CO2. 
Then, the gels were incubated with 500 μL of low (2.5 mM) or high (25 mM) glucose KRB for 2 
hours each. The low and high glucose buffer solutions were collected and analyzed using mouse 
insulin ELISA kit (Mercodia). Cell viability was further quantified by CellTiter Glo® assay 
(Promega). Insulin secretion obtained from ELISA was normalized by the respective ATP content 
of the cell-laden hydrogels.  
Data analysis 
All experiments were conducted independently for three times and results were reported 
as mean ± SD. Data was analyzed with student’s t-test using GraphPad Prism 5 (p < 0.05).  
 
RESULTS AND DISCUSSION 
Tyrosine-assisted crosslinking of thiol-norbornene PEG-peptide hydrogels 
 We first evaluate the influence of soluble tyrosine on the gelation kinetics of PEG-peptide 
hydrogels formed by visible light initiated thiol-norbornene polymerization. Gelation was carried 
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out using PEG8NB, a bis-cysteine-containing peptide crosslinker (i.e., CGGGC), and 
photoinitiator eosin-Y (Figure 1A). Soluble tyrosine was also added in some samples. The 
gelation kinetics was monitored by in situ photorheometry using a visible light source (Figure 1B 
and 1C). We found that PEG-peptide hydrogels crosslinked without soluble tyrosine had a gel 
point of about 100 seconds. After 300 seconds of visible light exposure, the shear modulus was 
only about 100 Pa (Figure 1B), indicative of poor gelation efficiency as compared with the gelation 
using 4-arm PEGNB and an inert crosslinker DTT [48]. Since visible light-mediated thiol-
norbornene gelation starts with the deprotonation of thiol group by excited eosin-Y, we suspected 
that the poor gelation efficiency shown in Figure 1B might be a result of insufficient deprotonation 
of thiol groups on cysteine residues, which were part of the peptide sequence. Furthermore, we 
found that gelation efficiency depends highly on the sequence of the bis-cysteine peptide 
crosslinkers (Figure S1). It has been reported that some amino acids (e.g., tyrosine, tryptophan) 
could increase the half-life of eosin-Y radicals [49, 50]. Therefore, we hypothesized that the 
addition of soluble tyrosine might enhance the crosslinking efficiency of visible light-based thiol-
norbornene hydrogels through improving eosin-Y mediated cysteine deprotonation. To test this 
hypothesis, 1 mM of soluble tyrosine was added in the prepolymer solution. The addition of 
soluble tyrosine shortened the gel point by five-fold to ~22 seconds, and increased the shear 
modulus of the gel by ten-fold to ~1,000 Pa (Figure 1C). The significant improvement of gelation 
efficiency in the presence of soluble tyrosine was indicative of an accelerated deprotonation of 
peptide-bound cysteine side-chain, which enhanced the thiol-norbornene coupling.  
 
Conversion of functional groups  
 To examine the kinetics of tyrosine-assisted thiol-norbornene reaction, we characterized 
thiol and norbornene consumptions in the presence of soluble tyrosine at different concentrations. 
In order to facilitate quantification of the thiol/norbornene consumptions, macromer components 
were selected such that no crosslinked network was formed following visible light exposure (i.e., 
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linear PEG-norbornene or PEGdNB, and soluble cysteine). Eosin-Y was used at 0.1 mM and 
soluble tyrosine was added at different concentrations (i.e., 0, 0.1, 1, 10 mM). After visible light 
exposure, the concentrations of free thiol remaining in the solution were quantified by Ellman’s 
assay and converted to percent thiol conversion. Figure 2 shows that percent thiol conversion 
was higher when soluble tyrosine was added at higher concentrations. For example, thiol 
conversion at 20 seconds (where gel point was previously determined, Figure 1C) increased from 
~22 % to ~48 % as the concentration of soluble tyrosine was increased from 0 to 10 mM (Figure 
2, right panel). The higher thiol conversion in the presence of soluble tyrosine could explain the 
faster gel point shown in Figure 1C. Interestingly, while the in situ photorheometry results showed 
that final gel moduli were affected by the presence of soluble tyrosine (Figure 1B and 1C), all 
non-gelling formulations eventually reached similar thiol conversion regardless of the amount of 
soluble tyrosine added (Figure 2, ~95 % at 300 seconds of visible light exposure). We believe 
that this was not caused by solution acidity change due to the addition of tyrosine as we found no 
significant differences in pH values of the non-gelling solution containing different tyrosine 
concentrations, either with or without cysteine (Figure S2). It was possible that the thiol-
norbornene reaction efficiency was higher in the non-gelling experiment than in the actual network 
crosslinking owing to the fact that some reactions in the latter led to dangling chains (i.e., network 
defects) that did not contribute to shear moduli of the resulting hydrogels. It was also likely that 
some deprotonated thiols formed disulfide bonds that did not contribute to network crosslinking. 
Nonetheless, the presence of soluble tyrosine increased the efficiency of thiol deprotonation, 
which was an important factor in the thiol-norbornene gelation. 
In addition to thiol conversion, we examined the consumption of norbornene groups in 
similar visible light initiated non-gelling thiol-norbornene reactions. Following the non-gelling 
reactions, the samples were dialyzed against ddH2O to remove small molecular weight by-
products (e.g., photoinitiator fragments, tyrosine, cysteine, etc.). The freeze-dried samples were 
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dissolved in chloroform-d and subjected to proton NMR evaluation. The areas under the 
norbornene peaks (Figure 3A, δ 5.8-6.2 ppm) were integrated to obtain the norbornene 
conversion. As the concentration of soluble tyrosine was increased from 0 to 10 mM, the areas 
under the norbornene peaks decreased from 0.753 to 0.454 a.u. (Figure 3B). Correspondingly, 
norbornene consumption increased from ~19% to 51% when the concentration of soluble tyrosine 
was increased from 0 to 10 mM (Figure 3B). Since the step-growth thiol-norbornene reaction is 
strictly orthogonal (i.e., no homo-polymerization between norbornene groups under current 
experimental conditions), the amount of norbornene consumed after the reaction could be 
attributed to thiol-norbornene coupling. It is worth noting that the degree of norbornene conversion 
was not as high as the thiol conversion even though all reaction mixtures were composed of equal 
molarity of thiol and norbornene groups. It was possible that, upon visible light exposure the 
excited eosin-Y abstracted protons from cysteinyl thiols and promoted other undesired thiol-based 
reactions (in addition to the thiol-norbornene reaction) including disulfide bond formation or other 
reactions that depleted free thiols. It was worth noting that, even in the presence of high tyrosine 
concentration (i.e., 10mM), only about half of the available norbornene moieties were consumed 
in the ‘non-gelling’ experiment, suggesting that other factors exist to complicate the visible light 
mediated thiol-norbornene reactions. While functional group conversion (either thiol or 
norbornene) in a ‘non-gelling’ experiment is not equivalent quantitatively to that happens during 
actual network crosslinking, the results from these ‘non-gelling’ experiments nonetheless have 
demonstrated that the addition of soluble tyrosine indeed improved the conjugation efficiency 
between cysteinyl thiol and norbornene groups. Since it is not unusual to observe network non-
ideality in step-growth hydrogels (especially with lower macromer concentrations) [31, 52], the 
enhanced visible light based thiol-norbornene reaction efficiency in the presence of soluble 
tyrosine provides an easy and effective route of improving the crosslinking visible light based thiol-
norbornene hydrogels.    
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Effect of tyrosine, macromer content and thiol-to-norbornene ratio on hydrogel properties 
 As stated above, the addition of soluble tyrosine could improve thiol-norbornene reaction 
efficiency. Here, we asked whether adding soluble tyrosine would improve the properties of visible 
light based thiol-norbornene PEG-peptide hydrogels. We utilized a simple bis-cysteine containing 
peptide (sequence: CGGGC) as the crosslinker and added soluble tyrosine at different 
concentrations in the pre-polymer solutions. PEG8NB-CGGGC hydrogels were prepared using 
the same visible light and eosin-Y mediated thiol-norbornene crosslinking and the hydrogels were 
characterized through measuring gel fraction, elastic modulus, and swelling ratio. As the 
concentration of soluble tyrosine was increased from 0 to 1 mM, gel fraction increased from 50 to 
65 % (Figure 4A), elastic modulus increased from 1 to 3 kPa (Figure 4B), and equilibrium 
swelling ratio decreased from ~16 to ~10 (Figure 4C). These metrics (i.e., accelerated gel points, 
increased gel modulus, improved functional group conversion, and changes in gel swelling ratio) 
were indicative of an improved crosslinking in the presence of soluble tyrosine. Interestingly, 
further increasing tyrosine from 1 mM to 10 mM led to a slight decrease in gel elastic modulus, 
as well as an increased in swelling ratio. The negative impact of high tyrosine concentration on 
gel properties was unexpected as the results obtained from thiol and norbornene consumption 
(Figures 2 and 3) showed a monotonic increase of functional group conversion. It is worth noting 
that higher functional group conversion seen in the non-gelling experiments could not be directly 
correlated to improved network crosslinking owing to the presence of network non-ideality. The 
presence of high content soluble tyrosine could also lead to undesired reactions, which complicate 
the experimental results. As in the other chemically crosslinked thiol-norbornene hydrogels, the 
physical properties of gels could still be tuned by varying PEG8NB macromer and the ratio of 
norbornene to thiol. In the presence of 1 mM soluble tyrosine during gelation, elastic moduli of 
visible light crosslinked thiol-norbornene hydrogels increased 25–fold (i.e., from 1.3 kPa to 32 kPa) 
when PEG8NB was increased from 3 wt% to 9 wt% (Figure S3A). Also in the presence of 1 mM 
soluble tyrosine, increasing ratio of norbornene to thiol from 0.6 to 1 led to a 26–fold increase in 
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elastic moduli (Figure S3B, 0.05 to 1.3 kPa). These studies demonstrated the high tunability of 
visible light polymerized step-growth PEG-peptide hydrogels [48, 52].  
 
Effect of soluble tyrosine on the spectrophotometric properties of eosin-Y 
  
 In addition to the alterations in gelation kinetics and hydrogel properties, we observed 
changes in physical appearance of the hydrogels in the presence of soluble tyrosine during visible 
light initiated thiol-norbornene gelation. The visible light crosslinked thiol-norbornene hydrogels 
were normally pink to red in color due to the presence of eosin-Y [53]. However, the addition of 
soluble tyrosine appeared to quench the redness of hydrogels in a dose-dependent manner 
(Figure 5A). Since the concentration of eosin-Y was the same across the four formulations, the 
disappearance of gel redness was potentially due to the quenching of eosin-Y by tyrosine through 
a proton-coupled electron transfer process [54, 55]. To verify this, we evaluated the 
spectrophotometric properties of precursor solution containing non-gelling components. Before 
exposing solution to light, the UV/Vis spectra of these solution were similar regardless of the 
concentration of tyrosine used (peak absorbance of ~0.5 at 516 nm, Figure 5B to 5E). However, 
after exposing the non-gelling solution to visible light, the peak absorbance (at 516 nm) of the 
solution decreased with increasing concentration of tyrosine (Figure 5B to 5E, 0.25 to 0.18 a.u. 
for 0 mM to 10 mM of tyrosine, respectively), which suggest that the presence of soluble tyrosine 
quenched the red color of eosin-Y. We believe that the presence of soluble tyrosine during visible 
light based thiol-norbornene photocrosslinking caused changes in eosin-Y excitation status, 
which led to enhanced deprotonation of thiol groups and increased thiol-norbornene reaction and 
gel crosslinking. The reduction in red color has an added benefit in fluorescence imaging as there 
was some overlapping in the emission spectra of eosin-Y and DNA labeling dyes (e.g., edithium 
homodimer 1). The quenching of eosin-Y by soluble tyrosine following photo-crosslinking is 
beneficial as this reduces the background fluorescence attributed by eosin-Y.   
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Cytocompatibility of tyrosine-assisted visible light-based thiol-norbornene PEG-peptide 
gel crosslinking 
 To explore the potential of tyrosine-assisted, visible light-based thiol-norbornene PEG-
peptide gel crosslinking in tissue engineering applications, we evaluated the cytocompatibility of 
this gelatin system using in situ encapsulation of pancreatic MIN6 β-cells. In this experiment, we 
utilized non-degradable 8-arm PEGNB (PEG8aNB, 20 kDa) as the base macromer to afford 
hydrolytically stable hydrogels throughout the course of study (Figure S4). In addition, we 
synthesized a laminin-derived peptide flanking with terminal cysteine residues (i.e., KCYIGSRCK, 
terminal lysine residues added to increase peptide solubility) as the hydrogel crosslinker to 
provide biomimicry to the otherwise inert PEG-based hydrogels [56-58]. Since the addition of 
soluble tyrosine during thiol-norbornene photopolymerization increased stiffness of the resulting 
gels, which could be a confounding factor when evaluating cellular fate, we formulated the cell-
laden hydrogels such that the elastic moduli of all hydrogels were similar (Figure S4, ~2 kPa). 
This was achieved through adjusting down the stoichiometric ratio of thiol to norbornene when 1 
mM of soluble tyrosine was added to the prepolymer solution (i.e., R[thiol]/[ene] = 1 for gelation without 
tyrosine and 0.85 for gelation with 1 mM of tyrosine).  
 After cell encapsulation, live/dead staining was performed and more than 80% of the MIN6 
β-cells were stained green, indicating that the gelation was cytocompatible for in situ cell 
encapsulation. However, we observed slightly more dead cells (~10%) when encapsulation was 
performed without soluble tyrosine (Figure 6A, top). Regardless of the initial cell viability, β-cells 
formed cell spheroids after 10 days of culture in both formulations (Figure 6A, bottom). In addition, 
AlamarBlue® reagent was used to quantify metabolic activity of the cells encapsulated within 
these hydrogels. Compared with cells encapsulated in the absence of tyrosine, cells encapsulated 
in the presence of tyrosine showed higher cell metabolic activity throughout the course of study 
(Figure 6B). Furthermore, β-cells encapsulated in the presence of tyrosine had higher insulin 
17 
 
secretion than cells encapsulated without the addition of tyrosine (Figure 6C, 2-fold and 3-fold 
higher on day 1 and 10, respectively). We further examined the expression of mouse insulin (ins) 
and pancreatic duodenal homeobox-1 (pdx1) on the mRNA level. These two genes were chosen 
because of their importance in glycemic control and in proliferation of pancreatic β-cells [59, 60]. 
The mRNA expression of ins and pdx1 showed that the addition of tyrosine did not create adverse 
influence on β-cells (Figure S5). In addition to encapsulating MIN6 β-cells, we also performed in 
situ encapsulation using isolated mouse islets (from CD1 mice). Live/dead staining images of the 
encapsulated islets showed that more dead cells when islets were encapsulated in the absence 
of tyrosine (Figure S6). These results confirmed that the addition of tyrosine during gelation did 
not negatively impact β-cells and islets viability. 
 Previous studies have shown that insulin secretion from islets and β-cells could be 
upregulated by selected amino acids [61]. To evaluate if the viability of encapsulated β-cells was 
influenced by the presence of soluble tyrosine, we performed a control study where cell 
encapsulation was performed in the absence of tyrosine. Following encapsulation, cell-laden gels 
were placed in media in the absence or presence of tyrosine (at 1 mM) for one hour prior to 
analyses. An incubation period of one hour was selected as it was sufficiently for tyrosine to 
diffuse into the cell-laden hydrogels. The live/dead staining images and Alarmarblue® reagent 
assay results showed that β-cells had similar viability and metabolic activity regardless of the 
media condition (i.e., with or without soluble tyrosine, Figure S7). These results indicate that the 
presence of soluble tyrosine alone was not sufficient to influence cell viability. Taken together, the 
results in Figure 6 and Figure S7 suggest that the presence of soluble tyrosine during visible 
light based thiol-norbornene gelation likely attenuated some adverse effects of excited eosin-Y 
radicals on cell viability. Although the current work demonstrates that the gelation efficiency and 
cytocompatibility of visible light based thiol-norbornene PEG-peptide hydrogels can be 
significantly improved by adding soluble tyrosine during gel crosslinking, future mechanistic work 
18 
 
is necessary to elucidate the potential biological effects of soluble tyrosine on β-cells viability and 
function.      
 
CONCLUSIONS 
In summary, we have synthesized visible light mediated step-growth thiol-norbornene 
photopolymerized hydrogel using multi-arm PEGNB and di-cysteine containing peptides. We 
found that thiol-norbornene hydrogels crosslinked in the presence of soluble tyrosine exhibited 
faster gelation kinetics and higher crosslinking efficiency. Furthermore, the network crosslinking 
depended highly on the amount of tyrosine, concentration of macromer, and the ratio of 
norbornene to thiol used. In addition, a series of cell viability tests revealed that hydrogels 
crosslinked in the presence of tyrosine preserved the viability and insulin secreting function of 
pancreatic β-cells. Together, these data suggest that tyrosine-assisted visible light mediated thiol-
norbornene polymerization should be of great value for fabricating PEG-peptide hydrogels in 
tissue engineering applications. 
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FIGURE CAPTIONS 
Figure 1. (A) Schematic of visible light and eosin-Y mediated thiol-norbornene gelation. (B) In situ 
photorheometry of thiol-norbornene photopolymerization between PEG8NB (3 wt%) and CGGGC 
(6 mM) in the absence of soluble tyrosine. (C) Gelation in the presence of 1 mM soluble tyrosine. 
G’: storage modulus; G”: loss modulus. Eosin-Y: 0.1 mM. Light intensity: 70 kLux. n= 3. Error bars 
were omitted for clarity. 
 
Figure 2. Thiol conversion quantified by Ellman’s assay. Non-gelling components used in the 
reaction mixtures were: 3.6 wt% PEGdNB (i.e., 12 mM norbornene), 12 mM L-cysteine (i.e., 12 
mM thiol), 0.1 mM eosin-Y and different concentrations of soluble tyrosine (n = 3). The right panel 
shows the shaded region in the left plot.  
 
Figure 3. (A) Effect of soluble tyrosine on norbornene conversion as determined by 1H NMR using 
non-gelling components: PEGdNB (3.6 wt%), soluble cysteine (12 mM), eosin-Y (0.1 mM), and 
tyrosine (0, 0.1, 1, and 10 mM). All samples were prepared in D2O (at 4.8 ppm). (B) Integration of 
the areas under the norbornene peaks and calculated norbornene group conversion in the 
presence of different soluble tyrosine concentration.  
 
Figure 4. Effect of soluble tyrosine on (A) gel fraction, (B) elastic moduli, and (C) swelling ratio. 
Gelation was performed with 3 wt% PEG8NB, 6 mM CGGGC, 0.1 mM eosin-Y, and different 
concentrations of soluble tyrosine under visible light exposure. * denotes p<0.05. 
 
Figure 5. (A) Photograph of hydrogels at equilibrium swelling (3 wt% PEG8NB, and 6 mM 
CGGGC). (B-E) UV-vis spectra of eosin-Y before (thick blue) and after (thin red) visible light 
exposure for 5 minutes using non-gelling components: 3.6 wt% PEGdNB; 6 mM CGGGC, and 
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different concentrations of soluble tyrosine: (B) 0 mM, (C) 0.1 mM, (D) 1 mM, and (E) 10 mM. 
Eosin-Y concentration in all measurements was 0.1 mM. 
 
Figure 6. Effect of soluble tyrosine on the cytocompatibility of MIN6 β-cells following visible light 
initiated thiol-norbornene gelation. (A) Representative confocal z-stack images of MIN6 cells 
stained with live/dead staining kit on day 1 (Scales: 100 μm). (B) Cell viability as assessed by 
Alamarblue® reagent. (C) Glucose stimulated insulin secretion (25 mM of glucose) normalized by 
cell metabolic activity. * indicates comparison between day 1 and day 10, while % indicates 
comparison between 0 to 1 mM of tyrosine, p < 0.05. All gel formulations contained β-cells at 
5×106 cells/mL, 3.5 wt% PEG8aNB, KCYIGSRCK, 0.1 mM eosin-Y. Ratio of [thiol] to [norbornene] 
was 1 and 0.85 for 0 mM and 1 mM of tyrosine, respectively 
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Biomimetic PEG-peptide hydrogel was developed through tyrosine-assisted visible-light thiol-
norbornene crosslinking. Soluble tyrosine improves crosslinking and enhances cytocompatibility 
of the hydrogels. 
